Repayment of Short Term Working Capital Facility

RNS Number : 6044J
Glantus Holdings PLC
14 December 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

Glantus Holdings plc

 

(''Glantus'' or the ''Company'')

 

Repayment of Short Term Working Capital Facility

 

Glantus (AIM: GLAN), the provider of Accounts Payable ("AP") automation and analytics solutions, is pleased to announce that the €1.5m additional short term working capital facility, which was drawn down from its existing Beach Point debt facility, as announced by the Company on 24 October 2022, has now been fully repaid as scheduled prior to 31 December 2022.

 

 

Enquiries:

 

 

Glantus Holdings

 

Maurice Healy, CEO

Diane Gray Smith, interim CFO

ir@glantus.com

 

+ 353 86 2677800 

Shore Capital  

 

Nominated Advisor and Broker

Patrick Castle / John More / Tom Knibbs

 

+ 44 207 408 4090

Yellow Jersey PR

 

Charles Goodwin

Lilian Filips

Annabelle Wills

 

+ 44 7747 788 221

About Glantus Holdings plc

Glantus Holdings (AIM: GLAN) Glantus is a global provider of accounts payable automation and analytics solutions. Glantus' mission is to harness technology to drive innovation, unlocking efficiencies in AP to maximise working capital for global enterprise organisations. The award-winning Glantus DataShark Platform connects all AP systems and suppliers on one agile platform, eliminating cost and delivering new revenue streams. We work in tandem with our partners to deliver joint enterprise digital transformation solutions. For more information see   glantus.com .

Founded in 2014 and headquartered in Dublin, Glantus has offices in the United States, United Kingdom, Poland and Costa Rica, employing over 100 people.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPGAUPUPPGRW
UK 100

Latest directors dealings